BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

  May 1, 2025

   · 

  1 min read
• Press Releases

  Nutcracker Therapeutics to Showcase NMU-Symphony™ Platform for Personalized Cancer Therapeutics at Leading Industry Conferences

  May 1, 2025

   · 

  3 min read
• Press Releases

  Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15

  May 1, 2025

   · 

  1 min read
• Press Releases

  Brightseed and Haleon Announce Strategic Collaboration to Harness AI for Small Molecule Discovery and Human Health Innovation

  May 1, 2025

   · 

  2 min read
• Press Releases

  Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

  May 1, 2025

   · 

  4 min read
• Press Releases

  Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

  May 1, 2025

   · 

  1 min read
• Press Releases

  Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

  May 1, 2025

   · 

  5 min read
• Press Releases

  Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

  May 1, 2025

   · 

  4 min read
• Press Releases

  Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches

  May 1, 2025

   · 

  8 min read
• Press Releases

  Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases

  May 1, 2025

   · 

  24 min read